PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Blockade of the PD-1 receptor has revolutionized the treatment of metastatic melanoma, with significant increases in overall survival (OS) and a dramatic improvement in patient quality of life. Despite the success of this approach, the number of benefitting patients is limited and there is a need fo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncoimmunology
Hoofdauteurs: Pico de Coaña, Yago, Wolodarski, Maria, van der Haar Àvila, Irene, Nakajima, Takahiro, Rentouli, Stamatina, Lundqvist, Andreas, Masucci, Giuseppe, Hansson, Johan, Kiessling, Rolf
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470181/
https://ncbi.nlm.nih.gov/pubmed/32939320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1786888
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items